thebench.bio #1 Ecosystem for the Bio-Tech Industry

Manufacturing Daily Summary

Manufacturing Daily Summary: What Happened on November 16, 2026

ProBioGen gains expanded GMP authorization for Berlin facility

The updated certificate adds viral products and advanced therapy medicines to the facility’s existing protein-manufacturing services.

  • Updated
  • Read from 1 article, 1 publication
  • P

Today in brief

ProBioGen received expanded manufacturing authorization for its Berlin facility, adding viral products and advanced therapy medicines to its GMP services.1

Manufacturing

An updated GMP certificate allows ProBioGen’s Berlin facility to produce sterile biological drug substances and investigational medicines, including viral vectors and vaccines.1 The facility has capacity for up to 200 liters of drug substance.1

Also published